Siemens completes acquisition of GSD

SIEMENSFollowing the announcement in January 2007 of its intent, Siemens Medical Solutions announced today that it has received antitrust approval and completed its acquisition of Gesellschaft fur Systemforschung und Dienstleistungen im Gesundheitswesen mbH (GSD), headquartered in Berlin. The new entity, Siemens Medical Solutions GSD GmbH, will remain a separate legal entity, operating as a wholly owned subsidiary of Siemens Medical Solutions as part of the Health Services (HS) Division. With this acquisition Siemens strengthens its position in the European healthcare IT market.

With more than 300 customers in 14 countries, GSD is a leading health information systems (HIS) company. With the addition of GSD's i.s.h.med and i.c.m.health product lines, the move enhances Siemens' global healthcare IT portfolio and infuses additional industry expertise into its product and service offerings for the European market. GSD generated a revenue of 23.6 million EUR and employed 167 people in fiscal year 2006 (ended December 31).

"We are pleased to officially welcome the talent and resources of GSD into our trendsetting healthcare IT portfolio," said Erich R. Reinhardt, member of the Managing Board of Siemens AG, and President and CEO of Siemens Medical Solutions. "As with our continued investments in our Soarian healthcare process management solution, which is distinguished by its unique architecture and workflow engine, and with the internationally successful health information system, i.s.h.med, we see tremendous potential for best practice sharing and optimized service and support for our customers through this investment in GSD."

The combined product portfolio is unique in its regional and functional market coverage, enabling Siemens to tailor its solution offerings for customers at various levels of IT sophistication and maturity.

"We remain steadfast in our commitment to improving the quality and reducing the cost of healthcare through IT, which has become an essential component of our global strategy as we move toward more personalized medicine," Reinhardt added. "Today, we are taking an important step in improving our market position in Germany and expanding our presence in Europe. Additionally, we have high expectations that the combined business expertise and industry knowledge of the HS and GSD teams will ensure that our product and service innovation continues, our customers are well-positioned to achieve their desired outcomes, and that we are successful in all markets we serve."

After the formation of Siemens Medical Solutions Diagnostics, following the acquisitions of Diagnostic Products Corporation (DPC) and Bayer Diagnostics, the acquisition of GSD is Siemens Medical Solutions' third acquisition in the past three quarters. These moves support Siemens' strategy of building the industry's first full service diagnostics company that combines diagnostic imaging, laboratory diagnostics and clinical information technology under one roof along the value chain.

Gesellschaft fur Systemforschung und Dienstleistungen im Gesundheitswesen mbH (GSD) is one of Europe's leading manufacturers and service providers of IT solutions for hospitals. Its circle of users comprises over 268 hospitals and hospital operators around the world and GSD provided support for over 54 hospitals in different SAP projects. For the past 25 years GSD's has been providing the healthcare sector with all the IT solutions required to run a modern hospital: from software development to hardware solutions, over planning, support and implementation of networks, to the complete outsourcing of system operations. The company generated a revenue of 23.6 million Euro and employed 167 people in the fiscal year 2006 (ended December 31). Further information at www.gsd.de

Siemens AG (Berlin and Munich) is a global powerhouse in electrical engineering and electronics. The company has around 475,000 employees (incl. discontinued operations) working to develop and manufacture products, design and install complex systems and projects, and tailor a wide range of services for individual requirements. Siemens provides innovative technologies and comprehensive know-how to benefit customers in over 190 countries. Founded more than 155 years ago, the company focuses on the areas of Information and Communications, Automation and Control, Power, Transportation, Medical, and Lighting. In fiscal 2006 (ended September 30), Siemens had sales from continuing operations of EUR 87.3 billion and net income of EUR 3.033 billion, according to U.S. GAAP. Further information is available on the Internet at: www.siemens.com

Siemens Medical Solutions of Siemens AG (NYSE:SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics - such as Diagnostic Products Corporation and Bayer Diagnostics - mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting www.siemens.com/medical

Most Popular Now

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

ChatGPT Performs as Well as Doctors for …

The artificial intelligence chatbot ChatGPT performed as well as a trained doctor in suggesting likely diagnoses for patients being assessed in emergency medicine departments, in a pilot study to be...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...

AI may Outperform Most Humans at Creativ…

Large language model (LLM) artificial intelligence (AI) chatbots may be able to outperform the average human at a creative thinking task where the participant devises alternative uses for everyday objects...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

AI and Machine Learning can Successfully…

Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and...